In conclusion, the presented study unveils the ameliorated effects of the PLE on COPD inflammation in vivo and in vitro, suggesting its potential therapeutic usages in COPD treatment and partly, through blocking the TLR4/Syk/PKC/NF-κB p65 signal pathway. This evidence concerns the gene PRRT2 and chronic obstructive pulmonary disease.